Skip to main content
. 2009 Jan 6;4(1):e4049. doi: 10.1371/journal.pone.0004049

Table 2. Surgical Mortality and 5-Survival of the Study Group.

Cervical Ovarian Endometrial
Overall pa Facility Hospital Volume Overall pa Facility Hospital Volume Overall pa Facility Hospital Volume
TF NTF pb HVC IVC LVC pc TF NTF pb HVC IVC LVC pc TF NTF pb HVC IVC LVC pc
Surgical Mortality (%)
30 day 1.5 0.8 1.7 0.04 0.9 1.3 2.5 <0.01 6.1 4.5 6.4 0.07 5.0 5.5 7.8 <0.01 3.7 2.0 3.9 0.08 2.9 3.5 5.2 <0.01
90 day 3.7 2.7 4.0 2.9 3.3 5.0 11.6 10.0 11.8 9.9 10.6 14.3 7.2 6.4 7.3 6.9 6.6 8.5
5 year Survival (Proportion Surviving %)
Overall 61.7 63.9 60.9 0.00 64.0 61.3 59.5 <0.01 39.5 43.9 38.8 <0.01 42.2 40.4 36.2 <0.01 67.3 65.4 67.5 0.24 66.0 68.9 67.1 <0.01
Age Groups
<40 76.0 <0.01 73.5 77.1 0.02 75.6 74.3 78.6 0.09 76.6 <0.01 77.4 76.3 0.91 75.9 77.6 76.5 0.98 87.7 <0.01 84.9 88.6 0.43 88.6 88.8 85.5 0.57
41–65 63.1 62.4 63.4 0.58 61.8 62.9 65.0 0.60 47.7 45.4 48.3 0.27 46.6 49.8 47.0 0.13 79.6 74.6 80.5 <0.01 77.2 81.3 81.0 <0.01
>65 41.4 45.7 40.6 0.00 46.5 40.8 39.3 <0.01 28.9 32.4 28.5 <0.01 32.3 29.8 25.6 0.00 58.2 52.8 58.8 0.00 56.2 60.1 58.4 <0.01
Race
Caucasian 63.2 <0.01 64.6 62.7 0.03 66.1 62.4 61.2 <0.01 39.7 <0.01 44.7 38.9 <0.01 42.2 40.7 36.5 <0.01 69.0 <0.01 68.6 69.0 0.57 67.7 70.5 68.9 <0.01
AA 54.2 61.7 49.8 <0.01 56.9 55.7 47.3 <0.01 33.7 36.4 32.9 0.08 39.6 33.7 29.1 <0.01 46.0 46.4 45.9 0.75 47.3 45.1 45.1 0.57
Other 67.5 59.3 69.9 0.41 58.2 72.2 68.6 0.53 57.1 56.3 57.3 0.93 41.7 70.0 56.4 0.33 74.7 64.3 76.1 0.23 71.1 83.3 68.6 0.42
Ethnicity
Hispanic 66.4 <0.01 65.3 67.2 0.33 66.8 67.9 63.1 0.18 42.2 0.07 47.0 40.6 0.01 46.9 44.1 36.3 <0.01 66.5 1.00 72.8 64.7 <0.01 66.4 71.4 65.2 0.16
Non-Hispanic 60.9 63.5 60.0 0.00 63.4 60.1 59.2 <0.01 39.3 43.6 38.6 <0.01 41.8 40.3 36.1 <0.01 67.2 64.0 67.6 0.02 65.6 68.7 67.3 <0.01
Primary Payor
insured 71.6 <0.01 70.1 72.0 0.58 71.1 71.7 72.0 0.92 47.8 <0.01 53.4 46.8 0.00 51.3 47.4 44.6 <0.01 77.8 <0.01 79.3 77.7 0.21 75.8 83.2 75.3 <0.01
non-insured 63.1 64.6 61.9 0.60 65.1 64.7 56.2 0.10 53.5 61.6 51.0 0.09 55.2 52.8 52.5 0.98 71.0 73.2 69.7 0.55 72.8 69.2 68.6 0.54
Medicare 52.0 59.7 50.7 0.10 59.8 53.5 47.1 0.08 37.8 44.6 37.0 0.01 39.5 38.8 34.6 <0.01 63.1 62.6 63.1 0.85 62.1 62.1 66.8 0.28
Medicaid 59.4 60.6 58.4 0.94 59.5 62.7 55.4 0.24 43.4 40.1 45.1 0.62 42.6 42.3 45.3 0.98 65.4 66.8 64.7 0.95 64.8 67.5 63.9 0.77
Medicare/Medicaid NOS 45.1 52.3 43.5 0.05 52.4 42.2 43.1 0.04 31.2 35.3 30.6 0.00 35.4 33.7 27.7 <0.01 58.3 54.3 58.8 0.54 56.5 60.2 58.1 0.13
Government 74.2 100.0 61.9 0.10 80.0 62.5 100.0 0.36 70.0 ND 77.8 0.11 84.6 50.0 ND 0.35 72.4 81.8 66.7 0.79 62.5 80.0 100.0 0.71
LN examined
none 55.9 <0.01 55.6 56.0 0.37 51.7 56.1 58.2 0.21 31.8 <0.01 37.1 31.0 <0.01 34.0 30.9 31.0 <0.01 65.9 <0.01 63.0 66.2 0.26 63.0 68.8 65.4 <0.01
1 through 10 65.8 63.6 66.6 0.24 60.9 68.4 71.6 0.05 53.7 52.8 54.0 0.87 49.6 56.5 58.7 0.21 71.0 71.2 70.9 0.82 69.8 72.1 71.8 0.55
11 through 20 77.4 74.6 78.8 0.19 76.9 77.9 78.2 0.78 60.7 58.5 61.3 0.57 61.3 64.1 53.0 0.46 73.5 79.0 72.2 0.05 74.0 73.2 71.6 0.65
21–30 80.7 74.9 84.5 0.00 81.2 80.6 77.1 0.82 68.4 78.8 66.3 0.16 71.6 62.8 68.0 0.41 71.0 76.1 70.2 0.21 70.4 71.7 73.1 0.86
>30 82.0 83.1 81.0 0.82 84.9 75.5 93.4 0.05 57.4 63.0 55.8 0.31 60.0 54.5 50.0 0.62 76.6 84.9 74.7 0.06 75.7 75.2 89.5 0.49
Unknown 59.5 62.1 58.6 0.01 40.6 43.8 40.1 0.00 41.8 43.0 37.5 <0.01 66.3 61.1 67.0 <0.01 64.1 67.7 67.3 <0.01
Tumor stage
Localized 81.0 <0.01 82.7 80.4 0.04 83.0 80.4 79.3 0.02 78.6 <0.01 81.3 78.1 0.10 81.6 78.3 76.2 0.01 77.9 <0.01 78.8 77.8 0.12 77.8 79.1 76.4 <0.01
Regional 48.6 51.2 47.4 0.02 50.5 48.8 45.2 <0.01 48.9 64.0 46.9 <0.01 55.3 46.4 45.0 <0.01 50.3 52.9 49.8 0.07 50.7 51.3 47.8 0.06
Distant 19.5 24.4 17.6 0.00 23.0 17.4 17.6 <0.01 25.8 31.6 24.7 <0.01 27.8 28.0 22.0 <0.01 20.3 19.1 20.6 0.52 17.3 23.2 22.1 0.01
Tumor Grade
Well differentiated 74.5 <0.01 74.7 74.4 0.85 76.1 72.5 74.9 0.79 68.4 <0.01 64.7 69.0 0.68 71.0 67.7 65.7 0.10 83.0 <0.01 83.1 83.0 0.55 82.4 83.9 82.5 0.25
Moderately differentiated 62.6 66.3 61.3 0.02 65.6 62.0 59.8 0.02 44.7 48.5 44.0 0.08 44.8 46.7 42.7 0.10 71.5 69.0 71.8 0.26 71.8 73.2 69.2 0.01
Poorly differentiated 54.3 59.8 51.9 <0.01 60.7 52.9 46.9 <0.01 31.9 34.9 31.3 0.00 33.6 33.8 27.2 <0.01 44.4 47.6 43.9 0.14 44.7 45.0 43.1 0.18
Undifferentiated 40.5 38.9 41.0 0.63 55.0 32.8 34.6 0.05 32.2 39.5 30.7 0.23 31.4 36.9 27.6 0.01 30.4 30.3 30.5 0.61 25.8 38.2 30.8 0.10
Surgical Extirpation
Yes 75.0 <0.01 76.5 74.4 0.04 76.5 75.4 72.5 <0.01 45.7 <0.01 47.2 45.4 0.07 46.3 46.6 44.1 <0.01 70.8 <0.01 68.6 71.1 0.08 69.4 72.4 70.6 <0.01
No 41.7 43.2 41.2 0.03 38.5 42.9 42.9 0.03 18.9 26.3 18.2 <0.01 22.8 18.0 17.4 <0.01 48.0 40.2 48.8 0.13 39.3 45.2 55.4 <0.01
Chemotherapy
Yes 40.5 <0.01 41.0 40.4 0.68 43.7 38.6 37.4 0.49 37.8 <0.01 42.9 36.6 <0.01 40.6 38.0 32.9 <0.01 30.9 <0.01 33.9 30.2 0.43 31.4 29.2 32.7 0.74
No 65.0 68.3 63.9 <0.01 68.5 64.7 62.0 <0.01 41.1 45.5 40.6 <0.01 44.6 42.8 37.9 <0.01 69.3 68.2 69.5 0.68 68.6 70.9 68.4 <0.01
Radiation
Yes 47.0 <0.01 50.5 45.7 0.00 47.4 48.1 44.6 0.01 40.7 0.29 43.1 40.4 0.74 43.1 41.5 35.8 0.28 60.1 <0.01 61.8 59.9 0.21 59.5 61.8 57.2 0.02
No 73.4 75.1 72.9 0.04 76.4 76.5 68.0 <0.01 39.4 44.0 38.6 <0.01 42.1 40.2 36.1 <0.01 69.5 66.5 69.9 0.04 68.3 71.6 68.7 <0.01

TF = teaching facility; NTF = non-teaching facility; HVC = high-volume center; IVC = intermediate volume center; LVC = low volume center; AA = African American; ND = not determined.

pa value = log rank analysis of survival between categorical variables.

pb value = log rank analysis of survival at TF vs NTF.

pc value = log rank analysis of survival at HVC vs. IVC vs. LVC.